Law FirmOpposition Filing Analysis

The comprehensive analysis of Hoffmann Eitle opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Hoffmann Eitle

Patent NumberTitleApplicantOpposition DateOpposition Company
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025KRKA
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 14, 2025SYNTHON
AdjuvantsSYNGENTA PARTICIPATIONSJun 24, 2025SASOL GERMANY
Method For Manufacturing A Batch Of Timepiece HairspringsSIGATECJun 18, 2025ICB INGENIEURS CONSEILS EN BREVETS
Disposable Incontinence Article In The Form Of BriefsPAUL HARTMANNJun 11, 2025ESSITY HYGIENE AND HEALTH AKTIEBOLAG
Process For Separating A Mixture With Measurement Of Purity Or Yield On An Intermediate TankNOVASEP PROCESSJun 10, 2025HOFFMANN EITLE
Fatty Acid CompositionNESTE OYJMay 12, 2025UPM KYMMENE
Decorative Sheet And Decorative Material Using SameDAI NIPPON PRINTINGApr 30, 2025PROFOL
Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAApr 29, 2025MODERNATX
Agent For Use In Treatment Or Prevention Of Ophthalmic DisordersCHIESI FARMACEUTICIApr 23, 2025STRAWMAN